Short Summary
Apple and ImberaTek settled their inter partes review disputes covering eight patents. The Board terminated all IPRs and treated the settlement agreement as confidential.
Detailed Summary
In June 2025, Apple Inc. filed petitions challenging eight ImberaTek LLC patents. Before the Board could institute any of the IPRs, the parties reached a comprehensive settlement agreement covering all disputes. The Board granted the joint motions to terminate the proceedings, ordered the settlement agreement to be treated as business‑confidential information, and dismissed all IPRs without any claim constructions or unpatentability findings.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Apple Inc. vs ImberaTek, LLC is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Abbott Diabetes Care Inc. et al.vsDexCom, Inc.
Abbott Diabetes Care Inc.'s IPR challenge against DexCom's glucose monitoring patent was instituted by the PTAB. The Board found a reasonable likelihood of success on anticipation and obviousness grounds over prior art reference Gross, despite acknowledging examination complexity. This decision advances Abbott's efforts to invalidate key claims in the medical device space.
Cisco Systems, Inc.vsDamaka, Inc.
Cisco has filed an IPR petition challenging Damaka's U.S. Pat. 11,930,362, which covers modular video‑conferencing software. The petition asserts obviousness over a combination of five prior‑art references and requests the Board to institute a trial and cancel claims 1‑28 and 75.
Tessell, Inc.vsNutanix, Inc.
Court decision.
Stingray Group Inc. et al.vsHernandez-Mondragon, Edwin et al.
The PTAB granted institution for the IPR against U.S. Patent 10,123,074, finding a reasonable likelihood of unpatentability based on Avellan. The decision confirmed that 'content provider' does not require originating the request.
Samsung Electronics Co., Ltd. et al.vsXiFi Networks R&D, Inc.
The PTAB granted institution for IPR2025-01207 after the petitioner met the likelihood of prevailing standard, but all related proceedings are currently stayed pending Director Review.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.